COMP <GO>
MPLT vs EOLS // EV/EBITDA & P/E VALUATION
MapLight Therapeutics Inc. (NASDAQ) VS. Evolus Inc. (NASDAQ) • 15-METRIC TALLY: MPLT 2
— EOLS 2
■ METRIC PARITY
LAST: $7.72 (-3.26%) • MKT CAP: $500.1M
valuation
—
LAST: $7.52 (-1.51%) • MKT CAP: $496.7M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MPLT VS. EOLS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MPLT | EOLS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 66.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.40% | -35.00% | +2.60 | MPLT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -9.20% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -11.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -17.40% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 11.60% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | EOLS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.5 | 46.1 | -14.65 | EOLS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $500.1M | $496.7M | $3.4M | MPLT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MPLT REV | EOLS REV | MPLT GROSS % | EOLS GROSS % | MPLT FCF | EOLS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $297.2M | — | 66.3% | -$138.6M | -$45.7M |
| FY 2024 | $0 | $266.3M | — | 68.5% | -$79.6M | -$19.5M |
| FY 2023 | — | $202.1M | — | — | — | -$34.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MPLT // BETA —
EOLS // BETA —